You Are Here:
This topic is in the process of being updated. Please go to the Update in Progress section to see the latest documents available.
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for chlamydial infection.
Release Date: June 2007
- The USPSTF recommends screening for chlamydial infection in all sexually active, nonpregnant young women ages 24 and younger and in older nonpregnant women who are at increased risk.
Grade: A Recommendation.
- The USPSTF recommends screening for chlamydial infection in all pregnant women ages 24 and younger and in older pregnant women who are at increased risk.
Grade: B Recommendation.
- The USPSTF recommends against routinely providing screening for chlamydial infection in women ages 25 and older, whether or not they are pregnant, if they are not at increased risk.
Grade: C Recommendation.
- The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydial infection in men.
Grade: I Statement.
Update in Progress
In an effort to make the USPSTF recommendations clearer and its processes more transparent, the Task Force is sharing drafts of many of its documents for public comment, including draft Research Plans and draft Recommendation Statements. As a result, the final Recommendation Statement is not yet available.
USPSTF members work with researchers from an independent Evidence-based Practice Center (EPC) to create a Research Plan that guides the systematic review of the evidence. The Research Plan consists of an analytic framework, key questions, and a literature search strategy or research approach.
|Research Plan||Related Items|
|Final Research Plan||N/A|
The research team at the Evidence-based Practice Center independently gathers and reviews the available published evidence to address the questions posed by the USPSTF. The resulting draft Evidence Review is critiqued by national subject matter experts before being finalized.
|Evidence Review||Related Items|
|Draft Evidence Review for Public Comment
(April 29–May 26, 2014)
The USPSTF reviews the Evidence Review, evaluates the benefits and harms of the clinical preventive service, and discusses and develops one or more preliminary specific recommendations. The resulting draft Recommendation Statement is posted on this Web site for public comment before being finalized.
|Recommendation Statement||Related Items|
|Draft Recommendation Statement for Public Comment*
(April 29–May 26, 2014)
|Consumer Fact Sheet (PDF File, 82 KB; PDF Help)|
* Note: Draft Recommendation Statements are by their nature not final, and should not be interpreted as to represent official USPSTF recommendations for practice. Draft Recommendation Statements are provided by the USPSTF for informational purposes only.
Current as of May 2014
Screening for Chlamydial Infection, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspschlm.htm